Literature DB >> 11418575

Multiple domains are required for the toxic activity of Pseudomonas aeruginosa ExoU.

V Finck-Barbançon1, D W Frank.   

Abstract

Expression of ExoU by Pseudomonas aeruginosa is correlated with acute cytotoxicity in a number of epithelial and macrophage cell lines. In vivo, ExoU is responsible for epithelial injury. The absence of a known motif or significant homology with other proteins suggests that ExoU may possess a new mechanism of toxicity. To study the intracellular effects of ExoU, we developed a transient-transfection system in Chinese hamster ovary cells. Transfection with full-length but not truncated forms of ExoU inhibited reporter gene expression. Inhibition of reporter activity after cotransfection with ExoU-encoding constructs was correlated with cellular permeability and death. The toxicity of truncated versions of ExoU could be restored by coexpression of the remainder of the molecule from separate plasmids in trans. This strategy was used to map N- and C-terminal regions of ExoU that are necessary but not sufficient for toxicity. Disruption of a middle region of the protein reduces toxicity. This portion of the molecule is postulated to allow the N- and C-terminal regions to functionally complement one another. In contrast to ExoS and ExoT, native and recombinant ExoU molecules do not oligomerize or form aggregates. The complex domain structure of ExoU suggests that, like other P. aeruginosa-encoded type III effectors (ExoS and ExoT), ExoU toxicity may result from a molecule that possesses more than one activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11418575      PMCID: PMC95324          DOI: 10.1128/JB.183.14.4330-4344.2001

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  42 in total

1.  Purification and characterization of exoenzyme S from Pseudomonas aeruginosa 388.

Authors:  S M Kulich; D W Frank; J T Barbieri
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

2.  Pertussis toxin-mediated ADP-ribosylation of target proteins in Chinese hamster ovary cells involves a vesicle trafficking mechanism.

Authors:  Y Xu; J T Barbieri
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

3.  Pseudomonas aeruginosa induces type-III-secretion-mediated apoptosis of macrophages and epithelial cells.

Authors:  A R Hauser; J N Engel
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

Review 4.  Towards deciphering the Helicobacter pylori cytotoxin.

Authors:  J M Reyrat; V Pelicic; E Papini; C Montecucco; R Rappuoli; J L Telford
Journal:  Mol Microbiol       Date:  1999-10       Impact factor: 3.501

5.  Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread.

Authors:  M Allewelt; F T Coleman; M Grout; G P Priebe; G B Pier
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

6.  Pseudomonas aeruginosa cystic fibrosis isolates induce rapid, type III secretion-dependent, but ExoU-independent, oncosis of macrophages and polymorphonuclear neutrophils.

Authors:  D Dacheux; B Toussaint; M Richard; G Brochier; J Croize; I Attree
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

7.  Expression of recombinant exoenzyme S of Pseudomonas aeruginosa.

Authors:  S M Kulich; D W Frank; J T Barbieri
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

8.  The eukaryotic host factor that activates exoenzyme S of Pseudomonas aeruginosa is a member of the 14-3-3 protein family.

Authors:  H Fu; J Coburn; R J Collier
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

9.  Exoproduct secretions of Pseudomonas aeruginosa strains influence severity of alveolar epithelial injury.

Authors:  I Kudoh; J P Wiener-Kronish; S Hashimoto; J F Pittet; D Frank
Journal:  Am J Physiol       Date:  1994-11

10.  Construction and characterization of chromosomal insertional mutations of the Pseudomonas aeruginosa exoenzyme S trans-regulatory locus.

Authors:  D W Frank; G Nair; H P Schweizer
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.609

View more
  39 in total

1.  Ubiquitin and ubiquitin-modified proteins activate the Pseudomonas aeruginosa T3SS cytotoxin, ExoU.

Authors:  David M Anderson; Katherine M Schmalzer; Hiromi Sato; Monika Casey; Scott S Terhune; Arthur L Haas; Jimmy B Feix; Dara W Frank
Journal:  Mol Microbiol       Date:  2011-11-21       Impact factor: 3.501

2.  Role of the membrane localization domain of the Pseudomonas aeruginosa effector protein ExoU in cytotoxicity.

Authors:  Jeff L Veesenmeyer; Heather Howell; Andrei S Halavaty; Sebastian Ahrens; Wayne F Anderson; Alan R Hauser
Journal:  Infect Immun       Date:  2010-05-17       Impact factor: 3.441

3.  A C-terminal domain targets the Pseudomonas aeruginosa cytotoxin ExoU to the plasma membrane of host cells.

Authors:  Shira D P Rabin; Jeffrey L Veesenmeyer; Kathryn T Bieging; Alan R Hauser
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

4.  Functional regions of the Pseudomonas aeruginosa cytotoxin ExoU.

Authors:  Shira D P Rabin; Alan R Hauser
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

5.  Activation of ExoU phospholipase activity requires specific C-terminal regions.

Authors:  Katherine M Schmalzer; Marc A Benson; Dara W Frank
Journal:  J Bacteriol       Date:  2010-01-22       Impact factor: 3.490

6.  Induced conformational changes in the activation of the Pseudomonas aeruginosa type III toxin, ExoU.

Authors:  Marc A Benson; Steven M Komas; Katherine M Schmalzer; Monika S Casey; Dara W Frank; Jimmy B Feix
Journal:  Biophys J       Date:  2011-03-02       Impact factor: 4.033

7.  In vitro assays to monitor the activity of Pseudomonas aeruginosa Type III secreted proteins.

Authors:  Stephanie L Rolsma; Dara W Frank
Journal:  Methods Mol Biol       Date:  2014

8.  Pseudomonas aeruginosa induces localized immunosuppression during pneumonia.

Authors:  Maureen H Diaz; Ciara M Shaver; John D King; Srinidhi Musunuri; Jeffrey A Kazzaz; Alan R Hauser
Journal:  Infect Immun       Date:  2008-07-28       Impact factor: 3.441

9.  Identification and Verification of Ubiquitin-Activated Bacterial Phospholipases.

Authors:  Maxx H Tessmer; David M Anderson; Adam M Pickrum; Molly O Riegert; Dara W Frank
Journal:  J Bacteriol       Date:  2019-01-28       Impact factor: 3.490

10.  Effect of metabolic imbalance on expression of type III secretion genes in Pseudomonas aeruginosa.

Authors:  Arne Rietsch; Matthew C Wolfgang; John J Mekalanos
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.